Corrigendum: Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation

Benzer Materyaller

• Corrigendum: Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation
  Yazar:: T Brown, ve diğerleri
  Baskı/Yayın Bilgisi: (2014-11-01)
• Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation
  Yazar:: T Brown, ve diğerleri
  Baskı/Yayın Bilgisi: (2013-07-01)
• Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation.
  Yazar:: Brown, T, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis
  Yazar:: J Greenhalgh, ve diğerleri
  Baskı/Yayın Bilgisi: (2011-09-01)
• Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.
  Yazar:: Greenhalgh, J, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)